394 related articles for article (PubMed ID: 20651586)
1. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.
Piconi S; Trabattoni D; Gori A; Parisotto S; Magni C; Meraviglia P; Bandera A; Capetti A; Rizzardini G; Clerici M
AIDS; 2010 Aug; 24(13):1991-2000. PubMed ID: 20651586
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.
Piconi S; Parisotto S; Rizzardini G; Passerini S; Terzi R; Argenteri B; Meraviglia P; Capetti A; Biasin M; Trabattoni D; Clerici M
Blood; 2011 Sep; 118(12):3263-72. PubMed ID: 21576701
[TBL] [Abstract][Full Text] [Related]
3. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
5. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
[TBL] [Abstract][Full Text] [Related]
6. Increased Regulatory T-Cell Activity and Enhanced T-Cell Homeostatic Signaling in Slow Progressing HIV-infected Children.
Roider J; Ngoepe A; Muenchhoff M; Adland E; Groll A; Ndung'u T; Kløverpris H; Goulder P; Leslie A
Front Immunol; 2019; 10():213. PubMed ID: 30809229
[TBL] [Abstract][Full Text] [Related]
7. Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.
Kasahara TM; Hygino J; Andrade RM; Monteiro C; Sacramento PM; Andrade AF; Bento CA
Hum Immunol; 2015 Oct; 76(10):701-10. PubMed ID: 26429325
[TBL] [Abstract][Full Text] [Related]
8. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
[TBL] [Abstract][Full Text] [Related]
9. HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection.
Kared H; Lelièvre JD; Donkova-Petrini V; Aouba A; Melica G; Balbo M; Weiss L; Lévy Y
AIDS; 2008 Nov; 22(18):2451-60. PubMed ID: 19005268
[TBL] [Abstract][Full Text] [Related]
10. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.
Al-Harthi L; Voris J; Patterson BK; Becker S; Eron J; Smith KY; D'Amico R; Mildvan D; Snidow J; Pobiner B; Yau L; Landay A
HIV Med; 2004 Jan; 5(1):55-65. PubMed ID: 14731171
[TBL] [Abstract][Full Text] [Related]
12. Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment.
Rueda CM; Velilla PA; Chougnet CA; Rugeles MT
PLoS One; 2013; 8(8):e71062. PubMed ID: 23967152
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.
Poizot-Martin I; Faucher O; Obry-Roguet V; Nicolino-Brunet C; Ronot-Bregigeon S; Dignat-George F; Tamalet C
J Clin Virol; 2013 Aug; 57(4):351-5. PubMed ID: 23664725
[TBL] [Abstract][Full Text] [Related]
14. High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts.
Bi X; Suzuki Y; Gatanaga H; Oka S
Eur J Immunol; 2009 Jan; 39(1):301-9. PubMed ID: 19089812
[TBL] [Abstract][Full Text] [Related]
15. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
[TBL] [Abstract][Full Text] [Related]
16. Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents - The-ANRS-EP59-CLEAC Study.
Frange P; Montange T; Le Chenadec J; Batalie D; Fert I; Dollfus C; Faye A; Blanche S; Chacé A; Fourcade C; Hau I; Levine M; Mahlaoui N; Marcou V; Tabone MD; Veber F; Hoctin A; Wack T; Avettand-Fenoël V; Warszawski J; Buseyne F
Front Immunol; 2021; 12():662894. PubMed ID: 33968064
[TBL] [Abstract][Full Text] [Related]
17. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
d'Ettorre G; Forcina G; Andreotti M; Sarmati L; Palmisano L; Andreoni M; Vella S; Mastroianni CM; Vullo V
Clin Exp Immunol; 2004 Feb; 135(2):280-5. PubMed ID: 14738457
[TBL] [Abstract][Full Text] [Related]
19. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
20. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
